Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Proton Rahman

Showing results (91-100 of 260) with videos related to

Pageof 26
Sort By:
Clinical Rheumatology|December 18, 2008
Cost-effectiveness modeling of abatacept versus other biologic agents in DMARDS and anti-TNF inadequate responders for the management of moderate to severe rheumatoid arthritisAnthony Russell, Ariel Beresniak, Louis Bessette, et al.
The Journal of Rheumatology|December 2, 2008
Association of interleukin 23 receptor variants with psoriatic arthritisProton Rahman, Robert D Inman, Walter P Maksymowych, et al.
Scientific Reports|May 19, 2015
Integrated genomics identifies convergence of ankylosing spondylitis with global immune mediated disease pathwaysMohammed Uddin, Dianne Codner, S M Mahmud Hasan, et al.
Arthritis and Rheumatism|April 3, 2008
Association of interleukin-23 receptor variants with ankylosing spondylitisProton Rahman, Robert D Inman, Dafna D Gladman, et al.
Rheumatology (Oxford, England)|December 6, 2018
Validation of new potential targets for remission and low disease activity in psoriatic arthritis in patients treated with golimumabLaura C Coates, Proton Rahman, Eliofotisti Psaradellis, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 30, 2014
Randomized controlled trial of adalimumab in patients with nonpsoriatic peripheral spondyloarthritisPhilip Mease, Joachim Sieper, Filip Van den Bosch, et al.
Arthritis Care & Research|May 29, 2015
Further Evidence Supporting a Parent-of-Origin Effect in Psoriatic DiseaseRemy A Pollock, Arane Thavaneswaran, Fawnda Pellett, et al.
Human Molecular Genetics|August 14, 2003
The Newfoundland population: a unique resource for genetic investigation of complex diseasesProton Rahman, Albert Jones, Joseph Curtis, et al.
Rheumatology International|November 24, 2007
Analysis of single nucleotide polymorphisms in Toll-like receptor 4 shows no association with ankylosing spondylitis in a Korean populationKyoung-Sun Na, Tae-Hwan Kim, Proton Rahman, et al.
BMC Rheumatology|December 9, 2020
Long-term effectiveness and safety of infliximab and golimumab in ankylosing spondylitis patients from a Canadian prospective observational registryProton Rahman, Michael Starr, Derek Haaland, et al.
Pageof 26

Showing results (91-100 of 260) with videos related to

Sort By:
Pageof 26
Clinical Rheumatology|December 18, 2008
Cost-effectiveness modeling of abatacept versus other biologic agents in DMARDS and anti-TNF inadequate responders for the management of moderate to severe rheumatoid arthritisAnthony Russell, Ariel Beresniak, Louis Bessette, et al.
The Journal of Rheumatology|December 2, 2008
Association of interleukin 23 receptor variants with psoriatic arthritisProton Rahman, Robert D Inman, Walter P Maksymowych, et al.
Scientific Reports|May 19, 2015
Integrated genomics identifies convergence of ankylosing spondylitis with global immune mediated disease pathwaysMohammed Uddin, Dianne Codner, S M Mahmud Hasan, et al.
Arthritis and Rheumatism|April 3, 2008
Association of interleukin-23 receptor variants with ankylosing spondylitisProton Rahman, Robert D Inman, Dafna D Gladman, et al.
Rheumatology (Oxford, England)|December 6, 2018
Validation of new potential targets for remission and low disease activity in psoriatic arthritis in patients treated with golimumabLaura C Coates, Proton Rahman, Eliofotisti Psaradellis, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 30, 2014
Randomized controlled trial of adalimumab in patients with nonpsoriatic peripheral spondyloarthritisPhilip Mease, Joachim Sieper, Filip Van den Bosch, et al.
Arthritis Care & Research|May 29, 2015
Further Evidence Supporting a Parent-of-Origin Effect in Psoriatic DiseaseRemy A Pollock, Arane Thavaneswaran, Fawnda Pellett, et al.
Human Molecular Genetics|August 14, 2003
The Newfoundland population: a unique resource for genetic investigation of complex diseasesProton Rahman, Albert Jones, Joseph Curtis, et al.
Rheumatology International|November 24, 2007
Analysis of single nucleotide polymorphisms in Toll-like receptor 4 shows no association with ankylosing spondylitis in a Korean populationKyoung-Sun Na, Tae-Hwan Kim, Proton Rahman, et al.
BMC Rheumatology|December 9, 2020
Long-term effectiveness and safety of infliximab and golimumab in ankylosing spondylitis patients from a Canadian prospective observational registryProton Rahman, Michael Starr, Derek Haaland, et al.
Pageof 26